Table 1.

Study characteristics

Author (Ref.)NPopulationIndex Test(s)Reference Standard% With Major Depressive Disorder Diagnosisa
Index Test (cutoff)Reference Standard
Alsuwaida and Alwahhabi (23)26HDSRQ (Arabic version)Clinical interviewNR15.4%
Balogun et al. (24)96Dialysis (HD/PD: NR)BDI-II, GDS-15Clinical interviewBDI-II (≥10): 37.1%, GDS-15 (≥5): 32.3% (subset n=62)30.6% (subset n=62)
Bautovich et al. (25)45HDBDI-II, CDIClinical interviewBDI-II/CDI: NR13.3%
Chilcot et al.(26)40HDBDI-II, CDIMINIBDI-II (≥16) on dialysis: 32.5%, off dialysis: 30%, CDI (≥10) on and off dialysis: 32.5%22.5% (off dialysis)
Collister et al. (27)b50HDSingle question from the ESASHADSESAS: NRHADS (≥7): 54%
Gencoz et al. (28)b45HDHam-DSCID-I (Turkish Translation)Ham-D: NR4% MDD (18% other depressive disorders)
Giordano et al. (29)b31HDGDS-15BDI-IIGDS-15 (≥6): 58%BDI-II (≥14): 61%
Grant et al. (30)c57HDBDI-IIClinical interview (based on ICD-10 diagnosis)BDI-II (≥10): 56.1%, BDI-II (≥15): 31.6%12.3%
Hedayati et al. (31)b98HDBDI-II, CDI, CES-D, Feinstein ScaleSCID-IBDI-II (≥14): 30.6%, CES-D (≥18): 30.6%17.3% MDD (26.5% any depressive disorders)
Loosman et al. (32)b62HD and PDBDI-II, HADSMINIBDI-II, HADS: NR; 33.9%
Neitzer, 2012 (33)134HDBDI-FSBDI-IIBDI-FS (≥4): 30.1%BDI-II (≥16): 28.7%
Preljevic et al. (34)b109HD and PDBDI-II, CDI, HADS-DSCID-IBDI-II (≥16): 20.8%, CDI (≥11): NR, HADS-D (≥8): 20.1%14.7% MDD (22% any depressive disorders)
Troidle et al. (35)b97CPD and HDTwo items from the KDQOL SF-36BDI-IIKDQOL SF-36: NRBDI-II (≥11): NR
van den Beukel et al. (36)b133HD: 72%MHI5 of the SF-36BDI-II/CDI (Dutch Translation)MHI5 (≤70): 39%BDI-II (≥16): 23% CDI (≥10): 23%
Watnick et al. (37)62HD and PDBDI-II, PHQ-9SCID-IBDI-II, PHQ-9: NR19.4%
Wang et al. (22)b319HDBDI-II, DI-MHD (Chinese language)SCID-IBDI-II (≥19): 20.7%, DI-MHD (≥25): 20%21.9%
  • HD, hemodialysis; SRQ, Self-Reporting Questionnaire; NR, not reported; PD, peritoneal dialysis; BDI-II, Beck Depression Inventory II; GDS-15, Geriatric Depression Scale 15; CDI, Cognitive Depression Index; MINI, Mini International Neuropsychiatric Interview; ESAS, Edmonton Symptom Assessment System; HADS: Hospital Anxiety and Depression Scale; Ham-D, Hamilton Depression Rating Scale; SCID-I, Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV; MDD, major depressive disorder; ICD-10, 10th revision of the International Statistical Classification of Diseases and Related Health Problems; CES-D, Center for Epidemiologic Studies–Depression Scale; BDI-FS, Beck Depression Inventory–Fast Screen; HADS-D, Hospital Anxiety and Depression Scale–Depressive Subscale; CPD, chronic pulmonary disease; KDQOL SF-36, Kidney Disease Quality of Life Short Form 36; MHI5, Mental Health Inventory 5; PHQ-9, Patient Health Questionnaire 9; DI-MHD, Depression Inventory–Maintenance Hemodialysis.

  • a The reported prevalence of major depressive disorder identified by the index test and the reference standard.

  • b Screened for depressive symptoms or milder forms of depression in addition to major depressive disorder.

  • c Included cutoff values for both major depressive disorder and for milder forms of depression and subclinical symptoms.